171 related articles for article (PubMed ID: 25203428)
41. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
[TBL] [Abstract][Full Text] [Related]
42. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
43. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
Chen Y; Chen H; Fu K; Zhu XZ; Irons R
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
[TBL] [Abstract][Full Text] [Related]
45. LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage.
Latchmansingh KA; Wang X; Verdun RE; Marques-Piubelli ML; Vega F; You MJ; Chapman J; Lossos IS
Mod Pathol; 2022 Sep; 35(9):1220-1226. PubMed ID: 35322192
[TBL] [Abstract][Full Text] [Related]
46. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.
Pan Z; Shen Y; Du C; Zhou G; Rosenwald A; Staudt LM; Greiner TC; McKeithan TW; Chan WC
Am J Pathol; 2003 Jul; 163(1):135-44. PubMed ID: 12819018
[TBL] [Abstract][Full Text] [Related]
47. MiR-223 Suppresses Proliferation and Promotes Apoptosis of Diffuse Large B-Cell Lymphoma Cells Through Lmo2 and MAPK Signaling Pathway.
Zhang Y; Zhang J
J BUON; 2021; 26(2):580-586. PubMed ID: 34077008
[TBL] [Abstract][Full Text] [Related]
48. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.
Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S
Hum Pathol; 2003 Jun; 34(6):610-6. PubMed ID: 12827616
[TBL] [Abstract][Full Text] [Related]
49. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
50. Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice.
Raboso-Gallego J; Casado-García A; Jiang X; Isidro-Hernández M; Gentles AJ; Zhao S; Natkunam Y; Blanco O; Domínguez V; Pintado B; Alonso-López D; De Las Rivas J; Vicente-Dueñas C; Lossos IS; Sanchez-Garcia I
Blood; 2021 Apr; 137(13):1741-1753. PubMed ID: 33024996
[TBL] [Abstract][Full Text] [Related]
51. Germinal center-specific protein human germinal center associated lymphoma directly interacts with both myosin and actin and increases the binding of myosin to actin.
Lu X; Kazmierczak K; Jiang X; Jones M; Watt J; Helfman DM; Moore JR; Szczesna-Cordary D; Lossos IS
FEBS J; 2011 Jun; 278(11):1922-31. PubMed ID: 21447067
[TBL] [Abstract][Full Text] [Related]
52. BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.
Ding J; Dirks WG; Ehrentraut S; Geffers R; MacLeod RA; Nagel S; Pommerenke C; Romani J; Scherr M; Vaas LA; Zaborski M; Drexler HG; Quentmeier H
Haematologica; 2015 Jun; 100(6):801-9. PubMed ID: 25769544
[TBL] [Abstract][Full Text] [Related]
53. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
54. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
55. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma.
Chen BB; Xu XP; Shen L; Han TJ; Lin ZG; Chen Z; Kang H; Huang B; Lin GW
Chin Med J (Engl); 2013 Feb; 126(3):482-7. PubMed ID: 23422111
[TBL] [Abstract][Full Text] [Related]
57. Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
Vazquez I; Papaleo N; Lop J; Puiggros A; Sanchez-Gonzalez B; Diez-Feijoo R; Gimeno E; Andrade-Campos M; Salar A; Espinet B; Salido M; Tapia G; Carreras J; Ferrer A; Arenillas L; Calvo X; Colomo L
Virchows Arch; 2021 Dec; 479(6):1073-1078. PubMed ID: 33811533
[TBL] [Abstract][Full Text] [Related]
58. Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
Natkunam Y; Vainer G; Chen J; Zhao S; Marinelli RJ; Hammer AS; Hamilton-Dutoit S; Pikarsky E; Amir G; Levy R; Yisraeli JK; Lossos IS
Haematologica; 2007 Feb; 92(2):176-83. PubMed ID: 17296566
[TBL] [Abstract][Full Text] [Related]
59. Focal follicular features in tonsillar diffuse large B-cell lymphomas: follicular lymphoma with diffuse areas or follicular colonization.
Ree HJ; Kikuchi M; Lee SS; Ohshima K; Yang WI; Ko YH; Cho EY; Rhee JC
Hum Pathol; 2002 Jul; 33(7):732-40. PubMed ID: 12196925
[TBL] [Abstract][Full Text] [Related]
60. HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.
Jiang X; Lu X; McNamara G; Liu X; Cubedo E; Sarosiek KA; Sánchez-García I; Helfman DM; Lossos IS
Blood; 2010 Dec; 116(24):5217-27. PubMed ID: 20844236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
